Skip to main content
PALI logo

Palisade Bio, Inc.

PALINASDAQHealthcareBiotechnology

$1.41Today:- (-)1Y −11.49%

As of Oct 16, 2026 close

Market cap
$325.53M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$1.32$2.86
Volume (live)
-
Avg. volume (3M)
3.40M

Palisade Bio (PALI) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Palisade Bio used $10.85M of cash in operating activities. Free cash flow was −$10.85M.

Palisade Bio Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Palisade Bio, Inc. (PALI) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-16.78-14.44-12.30-14.26-26.62-10.32-8.35-4.92-15.67
Depreciation & Amortization0.000.000.000.000.000.000.140.190.29
Deferred Income Tax0.000.000.000.000.00-0.040.000.000.00
Stock Based Compensation3.960.650.621.031.892.010.001.091.77
Change in Working Capital1.641.390.401.25-4.762.390.21-0.34-2.15
Change in Accounts Receivable0.000.000.000.000.08-0.060.270.08-0.25
Change in Inventory0.000.000.000.000.00-0.950.000.04-11.75
Change in Accounts Payable0.620.82-0.490.400.001.01-0.02-0.04-1.52
Change in Other Working Capital-0.090.630.890.85-4.841.44-0.05-0.38-0.38
Other Operating Activities-0.090.200.14-1.3914.710.110.74-2.296.47
Net Cash from Operating Activities-10.85-12.19-11.13-13.36-14.77-4.77-7.26-7.69-13.42
Investing Activities
Capital Expenditures0.000.000.00-0.010.00-0.010.000.00-0.09
Acquisitions0.000.000.000.00-0.050.000.000.000.08
Purchases of Investments0.000.000.000.000.000.000.000.00-5.00
Sales/Maturities of Investments0.000.000.000.000.000.000.005.005.00
Other Investing Activities0.000.000.000.000.000.000.000.00-0.08
Net Cash from Investing Activities0.000.000.00-0.01-0.05-0.010.005.00-0.09
Financing Activities
Debt Repayment-0.32-0.43-0.39-0.79-0.180.800.04-0.01-3.75
Common Stock Issued128.2210.959.4214.405.211.186.551.838.74
Common Stock Repurchased0.00-0.030.000.000.000.000.000.000.00
Other Financing Activities-1.11-0.922.161.6519.58-0.090.000.000.00
Net Cash from Financing Activities134.449.5811.1915.2624.611.896.591.814.99
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.00-0.01-0.010.00
Net Change in Cash123.59-2.610.051.899.78-2.88-0.67-0.89-8.52
Cash at Beginning of Period9.8512.4612.4110.520.743.625.796.6715.19
Cash at End of Period133.449.8512.4612.4110.520.745.115.796.67
Free Cash Flow-10.85-12.19-11.14-13.37-14.77-4.77-7.26-7.69-13.51
Supplemental Disclosures
Interest Paid-0.010.010.010.060.06---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Palisade Bio Cash Flow

What is Palisade Bio's free cash flow?

Palisade Bio had negative free cash flow of $10.85M in fiscal 2025 (fiscal year ended Dec 31, 2025).

Does Palisade Bio pay dividends or buy back shares?

Palisade Bio's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition